Early Real-World Treatment Patterns and Clinical Outcomes in Patients with Metastatic Breast Cancer Treated with Eribulin After Prior Immuno-Oncology or Antibody-Drug Conjugate Therapy.

Goyal, Ravi K; Zhang, Jingchuan; Davis, Keith L; Sluga-O'Callaghan, Martina; Kaufman, Peter A

Goyal, Ravi K; Zhang, Jingchuan; Davis, Keith L; Sluga-O'Callaghan, Martina; Kaufman, Peter A.

Afiliação

Goyal RK; Health Economics, RTI Health Solutions, Research Triangle Park, NC, USA.
Zhang J; Eisai Inc., Nutley, NJ, USA.
Davis KL; Health Economics, RTI Health Solutions, Research Triangle Park, NC, USA.
Sluga-O'Callaghan M; Health Economics, RTI Health Solutions, Research Triangle Park, NC, USA.
Kaufman PA; Larner College of Medicine, Division of Hematology/Oncology, University of Vermont Cancer Center, Burlington, VT, USA.

Breast Cancer (Dove Med Press) ; 15: 855-865, 2023.

Article em En | MEDLINE | ID: mdl-38020049

Palavras-chave

antibody drug conjugates; eribulin; immuno-oncology; metastatic breast cancer; patient medical chart review; real world evidence

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article